CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹1.01 Cr | - | - | - |
What is the latest Contingent Liabilities ratio of CORONA REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1.01 Cr |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
How is Contingent Liabilities of CORONA REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.01 Cr | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | - | |
Compare Contingent Liabilities of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,456.4 Cr | -1.7% | 3.5% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -1.7% |
3.5% |
|
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses